Azul Optics, founded in 2016 and headquartered in the United Kingdom, is an innovative player in the Health Care industry. The company is gaining attention for its cutting-edge screening tool, the MP-eye, which helps in preventing eye diseases by engaging patients and eye care professionals effectively.
The company's slogan, "MP-eye score increases patient use of sunglasses/photochromics, blue filtering lenses and macular pigment supplements," highlights its core mission to enhance patient behaviors towards eye protection. The MP-eye offers a quantitative evaluation that supports eye care professionals' recommendations, fostering patient investment in protective eye products.
Azul Optics last secured a Series B investment on 07 April 2017 from Parkwalk Advisors. This capital infusion has likely supported the company's efforts to enable eye care professionals to differentiate their practices and boost revenues through preventive product sales.